202 related articles for article (PubMed ID: 38779538)
21. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
22. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.
Kew MC
Liver Int; 2003 Dec; 23(6):405-9. PubMed ID: 14986813
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Characterization of
Jaruga P; Tomar R; Kant M; Vartanian V; Sexton B; Rizzo CJ; Turesky RJ; Stone MP; Lloyd RS; Dizdaroglu M
ACS Omega; 2023 Apr; 8(16):14841-14854. PubMed ID: 37125130
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
25. Mass Spectrometry-Based Method to Measure Aflatoxin B
Bellamri M; Yao L; Tomar R; Vartanian V; Rizzo CJ; Stone MP; Groopman JD; Lloyd RS; Turesky RJ
Chem Res Toxicol; 2024 Apr; 37(4):633-642. PubMed ID: 38498000
[TBL] [Abstract][Full Text] [Related]
26. Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
J Biol Chem; 2014 Jun; 289(26):18497-506. PubMed ID: 24838242
[TBL] [Abstract][Full Text] [Related]
27. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
[TBL] [Abstract][Full Text] [Related]
29. Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.
Gramantieri L; Gnudi F; Vasuri F; Mandrioli D; Fornari F; Tovoli F; Suzzi F; Vornoli A; D'Errico A; Piscaglia F; Giovannini C
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458213
[TBL] [Abstract][Full Text] [Related]
30. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
31. Effect of 8-oxoguanine glycosylase deficiency on aflatoxin B1 tumourigenicity in mice.
Mulder JE; Turner PV; Massey TE
Mutagenesis; 2015 May; 30(3):401-9. PubMed ID: 25583175
[TBL] [Abstract][Full Text] [Related]
32. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
33. Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.
Sriwattanapong K; Slocum SL; Chawanthayatham S; Fedeles BI; Egner PA; Groopman JD; Satayavivad J; Croy RG; Essigmann JM
Toxicol Sci; 2017 Nov; 160(1):173-179. PubMed ID: 28973694
[TBL] [Abstract][Full Text] [Related]
34. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
35. Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution.
Coskun E; Jaruga P; Vartanian V; Erdem O; Egner PA; Groopman JD; Lloyd RS; Dizdaroglu M
Chem Res Toxicol; 2019 Jan; 32(1):80-89. PubMed ID: 30525498
[TBL] [Abstract][Full Text] [Related]
36. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
37. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
38. Liver DNA adducts in methyl-deficient rats administered a single dose of aflatoxin B1.
Mehta R; Laver GW; Stapley R; McMullen E
Carcinogenesis; 1992 Jul; 13(7):1241-7. PubMed ID: 1638693
[TBL] [Abstract][Full Text] [Related]
39. Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1.
Ilic Z; Crawford D; Vakharia D; Egner PA; Sell S
Toxicol Appl Pharmacol; 2010 Feb; 242(3):241-6. PubMed ID: 19850059
[TBL] [Abstract][Full Text] [Related]
40. Synergism in actions of HBV with aflatoxin in cancer development.
Jin J; Kouznetsova VL; Kesari S; Tsigelny IF
Toxicology; 2023 Nov; 499():153652. PubMed ID: 37858775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
